Legal Representation
Attorney
Edwin Flores
USPTO Deadlines
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 4, 2015 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 4, 2015 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 22, 2014 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 22, 2014 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 26, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 23, 2014 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 21, 2014 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 21, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 5, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 4, 2014 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 2, 2014 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 2, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 24, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 23, 2013 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 12, 2013 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 12, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 7, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 6, 2013 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 5, 2013 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 5, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 24, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 23, 2012 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 16, 2012 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 23, 2012 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 16, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 7, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 7, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 18, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 5, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 28, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 6, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 3, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 2, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 2, 2011 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Oct 5, 2011 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 5, 2011 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 5, 2011 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 3, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 3, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 3, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 14, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 14, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 14, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 8, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 21, 2011 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| May 20, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 20, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicines, namely, biologic, anti-cancer DNA and RNA preparations, for use in the treatment of cancer; veterinary and medicinal preparations, namely, plasmid containing lipolexes, anti-cancer DNA preparations, and plasmid based therapeutic preparations, for use in the treatment of cancer, and for use in genetic therapy; pharmaceutical preparations and pharmaceutical substances for gene therapy; biological preparations for the treatment of cancer
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
SUPER CLEAN
Classification
International Classes
005